Atypical glandular cells - An update

被引:35
作者
Cangiarella, JF
Chhieng, DC
机构
[1] NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA
[2] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
关键词
AGC; Bethesda system; cervicovaginal cytology; Pap smear;
D O I
10.1002/dc.10316
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The diagnostic category of atypical glandular cells (AGC) in the Bethesda system for the reporting of cervicovaginal cytology has undergone significant modification since its inception in 1988. More than a decade later, this category remains a diagnostic challenge to both clinicians and cytopathologists because of the lack of uniform cytologic criteria, the lack of interobserver agreement in the diagnosis, and the lack of standardized patient management guidelines. This article reviews the current classification of A GC in the Bethesda system, the cytomorphologic features and differential diagnosis, the clinical significance of a diagnosis of AGC, and the clinical management of patients with AGC. This article provides a comprehensive clinicopathologic review of the category of AGC. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 93 条
[1]   ADENOCARCINOMA INSITU OF THE UTERINE CERVIX - A CLINICOPATHOLOGIC STUDY OF 36 CASES [J].
ANDERSEN, ES ;
ARFFMANN, E .
GYNECOLOGIC ONCOLOGY, 1989, 35 (01) :1-7
[2]   ThinPrep Pap Test - Accuracy for glandular disease [J].
Ashfaq, R ;
Gibbons, D ;
Vela, C ;
Saboorian, MH ;
Iliya, F .
ACTA CYTOLOGICA, 1999, 43 (01) :81-85
[3]  
Austin RM, 1998, ACTA CYTOL, V42, P178
[4]   Adenocarcinoma in situ of the cervix:: Management and outcome [J].
Azodi, M ;
Chambers, SK ;
Rutherford, TJ ;
Kohorn, EI ;
Schwartz, PE ;
Chambers, JT .
GYNECOLOGIC ONCOLOGY, 1999, 73 (03) :348-353
[5]  
Bai HW, 2000, DIAGN CYTOPATHOL, V23, P19, DOI 10.1002/1097-0339(200007)23:1<19::AID-DC4>3.0.CO
[6]  
2-K
[7]  
BETSILL WL, 1986, ACTA CYTOL, V30, P115
[8]  
BIRDSONG GG, 2002, ACTA CYTOL, V46, P922
[9]  
Biscotti CV, 1997, DIAGN CYTOPATHOL, V17, P326, DOI 10.1002/(SICI)1097-0339(199711)17:5<326::AID-DC4>3.0.CO
[10]  
2-8